SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB/A - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]: [Amend]
SEC Accession No. 0001169232-03-000951
Filing Date
2003-02-12
Accepted
2003-02-11 21:29:03
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10KSB d53572_10ksba.htm 10KSB/A 577576
3 CONSENT OF ERNST & YOUNG LLP d53572_ex23-1.htm EX-23.1 1903
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d53572_ex99-1.htm EX-99.1 3045
5 CERTIFICATION OF CONTROLLER d53572_ex99-2.htm EX-99.2 3115
  Complete submission text file 0001169232-03-000951.txt   587754
Mailing Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045
Business Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045 847-573-8990
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB/A | Act: 34 | File No.: 000-16929 | Film No.: 03551486
SIC: 2834 Pharmaceutical Preparations